Latest filing published 03 Jun 2026 for Amphastar Pharmaceuticals, Inc..
No signal scores available.
This profile gathers the share dealings of David Russell Gaugh in Amphastar Pharmaceuticals, Inc. The record holds 2 filings, for trades running from 18 July 2025 to 1 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 3 June 2026 came the latest disclosure, a share grant in Amphastar Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations